Status:
COMPLETED
Early Warning of Intradialytic Hypotension in Hemodialysis Patients
Lead Sponsor:
Biobeat Technologies Ltd.
Conditions:
Hypotension of Hemodialysis
Eligibility:
All Genders
18-120 years
Brief Summary
In this study, the investigators will monitor patients undergoing hemodialysis treatment with a non-invasive wearable PPG-based device. Measurements will include blood pressure, heart rate, oxygen sat...
Eligibility Criteria
Inclusion
- Patients with EKSD undergoing chronic hemodialysis treatments for \> 3 months.
- Patients must be able to adhere to the visit schedule and protocol requirements and be available to complete the study.
- Patients must satisfy a medical examiner about their fitness to participate in the study.
- Patients must provide written informed consent to participate in the study.
Exclusion
- Patients with an inability to communicate well with the Principal investigator (PI) and staff (i.e., language problem, poor mental development, or impaired cerebral function).
- Withholding the dialysis session for any reason prior to initiation.
- Minors under the age of 18.
Key Trial Info
Start Date :
January 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 15 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04680039
Start Date
January 15 2021
End Date
March 15 2022
Last Update
July 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Hadassah Ein Kerem Medical Center
Jerusalem, Israel, 91120